The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance

Area of Science:

• Microbiology
• Molecular Biology
• Antimicrobial Resistance

Background:

• The vanGCd gene cluster, homologous to vanG in Enterococcus faecalis, is prevalent in Clostridium difficile.
• Emergence of vancomycin resistance in C. difficile poses significant clinical threats.

Purpose of the Study:

• To investigate the functional capacity of the vanGCd gene cluster in conferring vancomycin resistance in C. difficile.
• To elucidate the mechanism by which vanGCd interacts with peptidoglycan synthesis.

Main Methods:

• Assessed the inducibility of vanGCd expression by vancomycin.
• Determined the enzymatic activities of VanGCd, VanXYCd, and VanTCd proteins.
• Performed trans-complementation experiments with the Enterococcus gallinarum vanC operon.
• Analyzed peptidoglycan precursors and mature peptidoglycan structure using mass spectrometry.

Main Results:

• VanGCd expression is inducible by vancomycin, and its associated enzymes (VanGCd, VanXYCd, VanTCd) exhibit functional ligase, dipeptidase, and racemase activities.
• Trans-complementation with E. gallinarum vanC operon did not confer vancomycin resistance in C. difficile.
• Sublethal vancomycin concentrations induced the production of modified peptidoglycan precursors, including UDP-MurNAc-pentapeptide[D-Ser].
• Observed amidation of UDP-MurNAc-tetrapeptide, UDP-MurNAc-pentapeptide[D-Ala], and UDP-MurNAc-pentapeptide[D-Ser], which was incorporated into the mature peptidoglycan.

Conclusions:

• The vanGCd gene cluster is transcriptionally and enzymatically functional in C. difficile.
• Despite its functionality, the vanGCd cluster is ultimately prevented from conferring vancomycin resistance in C. difficile.
• The study reveals a novel modification pathway in peptidoglycan synthesis involving amidation, which may be a target for future antimicrobial strategies.